Related Experiment Video
Updated: May 4, 2026
12:14
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
35.7K
Leukocyte-mediated tissue injury in ischemic stroke
1Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, 1501 Kings Hwy, Shreveport, LA, USA. dgrang@lsuhsc.edu.
Current Medicinal Chemistry
|December 31, 2013
Summary
Brain inflammation involving leukocytes contributes to stroke damage. This review explores leukocyte roles in ischemic stroke and potential treatments targeting these inflammatory responses.
Area of Science:
- Neuroscience
- Immunology
- Pathophysiology
Background:
- Ischemic stroke is a major global health concern with poorly understood causes.
- Brain inflammation is a key response to ischemic injury, linked to dysfunction and tissue damage.
- Leukocytes (white blood cells) are increasingly implicated in stroke pathophysiology.
Purpose of the Study:
- To review the role of leukocytes in the pathophysiology of ischemic stroke.
- To discuss mediators involved in leukocyte recruitment and activation in the post-ischemic brain.
- To examine the products of leukocyte activation contributing to stroke injury.
- To address potential therapeutic strategies targeting leukocyte activity.
Main Methods:
- Literature review of existing research on leukocytes and ischemic stroke.
- Analysis of inflammatory mediators and their role in leukocyte behavior.
- Discussion of cellular mechanisms underlying stroke-induced brain injury.
- Evaluation of recent therapeutic compounds tested for stroke treatment.
Main Results:
- Leukocyte infiltration and activation are significant contributors to brain damage after ischemic stroke.
- Specific inflammatory mediators drive leukocyte recruitment and exacerbate tissue injury.
- Products released by activated leukocytes contribute to neurological deficits and tissue damage.
- Emerging therapeutic compounds show promise by modulating leukocyte activity.
Conclusions:
- Leukocyte-mediated inflammation is a critical factor in ischemic stroke progression.
- Targeting leukocyte recruitment, activation, or their products offers potential therapeutic avenues.
- Further research into these mechanisms could lead to novel stroke treatments.
More Related Videos
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
01:15Ischemic Stroke l: Introduction
44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
01:29Hemorrhagic Stroke ll: Pathophysiology
30
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30
01:26Transient Ischemic Attack l: Introduction
18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18
01:17Hemorrhagic Stroke l: Introduction
20
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
01:21Cytotoxic Edema: Pathophysiology
20
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20